Brief: Hytn Announces Proposed Spin-Out Of Bpc-157 Peptide Drug Development Business
23/04/2026 23:05
April 23 (Reuters) - HYTN Innovations Inc HYTN.CD: HYTN ANNOUNCES PROPOSED SPIN-OUT OF BPC-157 PEPTIDE DRUG DEVELOPMENT BUSINESS HYTN INNOVATIONS INC - BOARD APPROVES SPIN-OUT OF PEPTIDE DRUG DEVELOPMENT BUSINESS INTO SPINCO HYTN INNOVATIONS INC - SPINCO TO PURSUE PUBLIC LISTING ON CANADIAN SECURITIES EXCHANGE Source text: ID:nGNX3tw45t Further company coverage: HYTN.CD ((Reuters.Briefs@thomsonreuters.com;))
Recent news on HYTN Innovations
See all newsBrief: Hytn Announces Extension Of Marketing Program
Brief: Hytn Announces Proposed Spin-Out Of Bpc-157 Peptide Drug Development Business
Brief: HYTN Initiates Sale Of Cannabis Products In Quebec Through Agreement With Rose
Brief: HYTN Announces Launch Of Rapid Onset Nano Gummies And Provides Commercial Update
Brief: Hytn Secures Cannabis Cultivation License To Elevate The Quality Of Its Cannabis Inputs